Iron infusion therapy is now available at our clinic which only takes 15 to 20 minutes. The iron infusion therapy is Ferinject (Ferric carboxymaltose) which was listed on PBS June 2014. If you have low iron studies and anaemia on blood tests and unable to tolerate oral iron tablets, iron infusion therapy is another alternative treatment available. It has very good safety profile with very rare occasion of anaphylaxis or anaphylactoid reaction. Other side effects are headache, nausea, abdominal pain and injection site reaction (includes possible skin staining from leakage of iron infusion). In the past, a doctor had to refer a patient to a hospital for iron infusion and been put on long waiting list. However, this will no longer necessary. Iron infusion procedure will cost $130 with Medicare rebate $38.20.(this does not include the cost of Ferinject)

NB: Patient will need to see a doctor first. The doctor will assess the patient and check on latest blood test results. The doctor will then write prescription for Ferinject. The patient will book a time for iron infusion to be done on designated day.

For patient who are eligible to receive government funded quadrivalent flu vaccine:

  • all individuals aged 65 years and over
  • all Aboriginal and Torres Strait Islander people aged 15 years and over
  • all children aged 6 months to less than 5 years (will be available in June 2018)
  • all pregnant women at any time during pregnancy
  • all residents of nursing homes and other long-term care facillities
  • individuals aged 6 months and over with medical conditions predisposing to severe influenza infection including
    1. Cardiac disease, including cyanotic congenital heart disease, coronary artery disease and congestive heart failure
    2. Chronic respiratory conditions, including suppurative lung disease, chronic obstructive pulmonary disease and severe asthma
    3. Other chronic illnesses requiring regular medical follow up or hospitalisation in the previous year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, and haemoglobinopathies
    4. Chronic neurological conditions that impact on respiratory function, including multiple sclerosis, spinal cord injuries, and seizure disorders
    5. Impaired immunity, including HIV, malignancy and chronic steroid use
    6. Children aged 6 months to 10 years on long term aspirin therapy
    7. Diabetes

From 8th April 2019 the Department of Health & Human Services is funding pertussis (whooping cough) vaccine for all pregnant women from 20 - 32 weeks gestation ideally to be given in every pregnancy. This provides two-for-one protection with the mother passing antibodies to the baby in utero.

The following groups will become eligible for free pertussis vaccine from 8th April 2019:

  • pregnant women from 20 - 32 weeks gestation during every pregnancy
  • partners of women who are at least 20 - 32 weeks pregnant if the partner has not received a pertussis booster in the last ten years
  • parents/guardians of babies born on or after 1 June 2015, if their baby is under six months of age and they have not received a pertussis booster in the last ten years.

The maximal risk of pertussis infection and severe morbidity is before infants are old enough to have received at least 2 vaccine doses. Around one in 200 infants under 6 months of age who are infected will die. Infants are most effectively protected by vaccinating their mothers during pregnancy. :

The Australian Immunisation Handbook, 10th Edition, 2013 (Pertussis chapter revised March 2015) states that "vaccination is recommended with each pregnancy to provide maximal protection to every infant; this includes pregnancies which are closely spaced (e.g. <2 years)" The optimal time for vaccination is between 20 and 32 weeks. However, the vaccine can be given at any time during the third trimester up to delivery